Dataset Preview
The full dataset viewer is not available (click to read why). Only showing a preview of the rows.
The dataset generation failed because of a cast error
Error code: DatasetGenerationCastError
Exception: DatasetGenerationCastError
Message: An error occurred while generating the dataset
All the data files must have the same columns, but at some point there are 7 new columns ({'Adverse Event; Dosage', '0', 'Request: DR. SONG WOULD like to be contacted at shensong@nephdocs.com. She currently is practicing at 601 W Golf Rd, Suite 105, Mount Prospect, IL 60056. She is dosing Farxiga 5mg because of she has seen an increase in creatinine and an increase potassium. She is interested in knowing any additional information regarding this. Mike Tarpey Renal MSL for ILLinois must contact dr.', 'Unnamed: 6', '2021-08-26 03:00:00', 'US', '6447467.0'}) and 7 missing columns ({'Customer Specialty', 'Inquiries', 'Az Global Insight Open Date', 'Az Global Insight Country', 'Case Number', 'Article Attachment', 'Az Category'}).
This happened while the csv dataset builder was generating data using
hf://datasets/hashir123/huma/test.csv (at revision 9ff25aa40b3d09e98c1c5494acfafb12bc0a37ad)
Please either edit the data files to have matching columns, or separate them into different configurations (see docs at https://hf.co/docs/hub/datasets-manual-configuration#multiple-configurations)
Traceback: Traceback (most recent call last):
File "/src/services/worker/.venv/lib/python3.9/site-packages/datasets/builder.py", line 2011, in _prepare_split_single
writer.write_table(table)
File "/src/services/worker/.venv/lib/python3.9/site-packages/datasets/arrow_writer.py", line 585, in write_table
pa_table = table_cast(pa_table, self._schema)
File "/src/services/worker/.venv/lib/python3.9/site-packages/datasets/table.py", line 2302, in table_cast
return cast_table_to_schema(table, schema)
File "/src/services/worker/.venv/lib/python3.9/site-packages/datasets/table.py", line 2256, in cast_table_to_schema
raise CastError(
datasets.table.CastError: Couldn't cast
6447467.0: double
2021-08-26 03:00:00: string
US: string
Request: DR. SONG WOULD like to be contacted at shensong@nephdocs.com. She currently is practicing at 601 W Golf Rd, Suite 105, Mount Prospect, IL 60056. She is dosing Farxiga 5mg because of she has seen an increase in creatinine and an increase potassium. She is interested in knowing any additional information regarding this. Mike Tarpey Renal MSL for ILLinois must contact dr.: string
Adverse Event; Dosage: string
0: string
Unnamed: 6: string
-- schema metadata --
pandas: '{"index_columns": [{"kind": "range", "name": null, "start": 0, "' + 1845
to
{'Case Number': Value(dtype='float64', id=None), 'Az Global Insight Open Date': Value(dtype='string', id=None), 'Az Global Insight Country': Value(dtype='string', id=None), 'Inquiries': Value(dtype='string', id=None), 'Az Category': Value(dtype='string', id=None), 'Customer Specialty': Value(dtype='string', id=None), 'Article Attachment': Value(dtype='string', id=None)}
because column names don't match
During handling of the above exception, another exception occurred:
Traceback (most recent call last):
File "/src/services/worker/src/worker/job_runners/config/parquet_and_info.py", line 1321, in compute_config_parquet_and_info_response
parquet_operations = convert_to_parquet(builder)
File "/src/services/worker/src/worker/job_runners/config/parquet_and_info.py", line 935, in convert_to_parquet
builder.download_and_prepare(
File "/src/services/worker/.venv/lib/python3.9/site-packages/datasets/builder.py", line 1027, in download_and_prepare
self._download_and_prepare(
File "/src/services/worker/.venv/lib/python3.9/site-packages/datasets/builder.py", line 1122, in _download_and_prepare
self._prepare_split(split_generator, **prepare_split_kwargs)
File "/src/services/worker/.venv/lib/python3.9/site-packages/datasets/builder.py", line 1882, in _prepare_split
for job_id, done, content in self._prepare_split_single(
File "/src/services/worker/.venv/lib/python3.9/site-packages/datasets/builder.py", line 2013, in _prepare_split_single
raise DatasetGenerationCastError.from_cast_error(
datasets.exceptions.DatasetGenerationCastError: An error occurred while generating the dataset
All the data files must have the same columns, but at some point there are 7 new columns ({'Adverse Event; Dosage', '0', 'Request: DR. SONG WOULD like to be contacted at shensong@nephdocs.com. She currently is practicing at 601 W Golf Rd, Suite 105, Mount Prospect, IL 60056. She is dosing Farxiga 5mg because of she has seen an increase in creatinine and an increase potassium. She is interested in knowing any additional information regarding this. Mike Tarpey Renal MSL for ILLinois must contact dr.', 'Unnamed: 6', '2021-08-26 03:00:00', 'US', '6447467.0'}) and 7 missing columns ({'Customer Specialty', 'Inquiries', 'Az Global Insight Open Date', 'Az Global Insight Country', 'Case Number', 'Article Attachment', 'Az Category'}).
This happened while the csv dataset builder was generating data using
hf://datasets/hashir123/huma/test.csv (at revision 9ff25aa40b3d09e98c1c5494acfafb12bc0a37ad)
Please either edit the data files to have matching columns, or separate them into different configurations (see docs at https://hf.co/docs/hub/datasets-manual-configuration#multiple-configurations)Need help to make the dataset viewer work? Make sure to review how to configure the dataset viewer, and open a discussion for direct support.
Case Number float64 | Az Global Insight Open Date string | Az Global Insight Country string | Inquiries string | Az Category string | Customer Specialty string | Article Attachment null |
|---|---|---|---|---|---|---|
2,772,396 | 2018-12-14 04:38:00 | ZA | Dear, Sr Annelise van Wyk at Parkview Intercare asked data regarding Forxiga - 1.Data in Type 1 Diabetics 2.Use with insulin in Type 2 Diabetes-safety and dosing of insulin Her email address is annelise.vanwyk@intercare.co.za. | Product Related Request | 0 | null |
7,235,292 | 2022-03-09 11:00:00 | US | Request: Nurse Practitioner had an off label question about HFpEF, and about any literature for initiating dosing at 5mg for HF, which I told her was not indicated in our HF prescribing information. Thank You | Heart Failure | Internal Medicine | null |
4,470,955 | 2020-01-28 03:00:00 | US | Request: What is the dosing algorithm for Farxiga and those on loop diuretics and chronic loop diuretics? | Drug Interactions/ Combination With | 0 | null |
4,002,746 | 2019-11-13 02:00:00 | US | Request: Provider asked about use of metformin in DECLRE TRIAL, dosing and percentage of patients on it. Please provide this information. | DECLARE Related | 0 | null |
3,385,167 | 2019-07-19 11:00:00 | US | Request: Is there a dosing schedule to wean a patient from insulin (Lantus) to Farxiga? | Adverse Event; Product Basic Information | 0 | null |
3,297,784 | 2019-06-16 07:17:00 | JP | Request: Is it possible to start dosing FXG from 10 mg? | Other | 0 | null |
3,179,003 | 2019-04-26 14:00:00 | US | AACE2019 Question: Interested in dosing of FARXIGA in T1DM. In addition, how you would titrate insulin when you add FARXIGA in T1DM? | Use in Special Populations | 0 | null |
3,050,128 | 2019-03-19 01:14:00 | JP | Request: I would like you to provide the following materials There is no particular deadline setting, and it does not matter if materials are provided separately from each MR in charge of each area. ＜FXG＞ ・ “Materials for Fosiga Patients (Medicine Bag Size)” (TSP420D) x 30 sheets ＜IRE＞ ・ “To patients and their families... | Other | 0 | null |
7,306,308 | 2022-04-05 12:00:00 | US | Request: Is there any data on dosing Farxiga 10mg BID? Please direct to Laura Showalter MSL. | Dosage | INTERNAL MEDICINE - ENDOCRINOLOGY, DIABETES & METABOLISM | null |
7,246,728 | 2022-03-11 09:50:00 | IT | Greene Comparative Effectiveness of Dosing of Medical Therapy for Heart Failure: From the CHAMP-HF Registry | Full Article Request; Heart Failure; Product Related Request; Therapeutic Area Related Request | 0 | null |
7,234,114 | 2022-03-08 13:18:00 | CA | PQC 833906 Patient emailed: "Hi. I have been taking this medication for the last several months, and I have to tell you that I really hate your packaging. As the world increasing becomes aware of the mountains of plastic and other waste that we all collectively produce, I want to know why this drug comes in wasteful bl... | Packaging | 0 | null |
5,282,544 | 2020-10-06 01:00:00 | US | Request: Any recommendations for dosing Farxiga in someone with a GFR in the 40-45 range? Any efficacy data with renal impaired patients? | DAPA-CKD/Renal Outcomes Related | 0 | null |
7,232,793 | 2022-03-07 17:00:00 | US | Request: Has Farxiga been studied with patients with proteinuria? What’s the dosing? Can FARXIGA lower proteinuria? MD is open to meet with MSL. | DAPA-CKD/Renal Related | INTERNAL MEDICINE - NEPHROLOGY | null |
7,106,913 | 2022-02-02 03:00:00 | US | Request: Please send data on dosing for using Farxiga in CKD patients. Do I need to start with 5mg? Or is 10mg ok? | Dosage | INTERNAL MEDICINE - NEPHROLOGY | null |
6,927,855 | 2021-12-03 01:56:00 | CA | information regarding the half- life of Forxiga. He is wondering if there could be any advantage in dosing Forxiga bid vs qd. | Pharmacology/Pharmacokinetics | General Practice | null |
6,927,851 | 2021-12-03 01:47:00 | CA | Concerned about dosing Forxiga 10 mg in CHF. He would like to know if there is any evidence for low dose use? Meaning 5 mg or less. | Dosage; Efficacy | GEPR | null |
6,782,725 | 2021-10-28 00:55:00 | CA | Please call pharmacist. He would like to know why the Forxiga 10mg can not be split/divided. He would like to know the rationale behind it. For my context please view SF 06778344 10-29-2021 (RN): Case transferred to me from my medical information associate colleague, CT, and reviewed notes left on cases 06782725 and 06... | Administration | PHME | null |
6,749,131 | 2021-10-21 04:59:00 | JP | Request: *Inquiries from the internet. The following、This document is documented. Please tell me about the dosage standards and the mandatory requirements for receipt in the indication of CKD for Fosiga. It doesn't matter if you answer via the person in charge of our hospital, so thank you. — Calling from the MIC and l... | DAPA-CKD/Renal Related | 0 | null |
6,651,604 | 2021-10-08 10:00:00 | US | Request: In the CKD study what was the dosing range patients were on for ace/arb? The patients on ACE/ARB maxed out on dosage before being placed on Farxiga? Do we have any comparison studies showing Farxiga is actually better than SOC therapy comparing to ACE/ARB? | DAPA-CKD/Renal Outcomes Related | Family Medicine | null |
6,631,602 | 2021-10-06 09:00:00 | US | Request: Are there any studies within US or European showing use or benefit of Farxiga 20mg? Can Farxiga 10mg be dosed twice a day? Side effects/contraindications of dosing this way? | Product Basic Information | Internal Medicine | null |
4,635,284 | 2020-02-26 10:00:00 | US | Request: HCP inquired about using dapagliflozin in a patient with a single kidney. reviewed renal data and dosing based on GFR, but would like to send her any additional information that may be available. | Precautions and Contra-Indications; Use in Special Populations | 0 | null |
5,416,189 | 2020-12-09 11:44:00 | US | Request: What is the dosing equivalence between Farxiga, Dapagliflozen, and other SGLT 2 medications? Is it low, medium or high? --The pharmacy director is looking for this information for a presentation on Wednesday, December 16, 2020. They are looking to add Farxiga to their formulary. | Dosage; Pharmacology/Pharmacokinetics | 0 | null |
6,462,796 | 2021-08-31 02:00:00 | US | Request: Physician would like to understand dosing regimen for FARXIGA for patients without CKD. For A1c control and then for heart failure. Also please send the dapa ckd clinical trial. Thanks | Dosage | Internal Medicine | null |
6,977,893 | 2021-12-16 11:36:00 | IN | Request: Need more information regarding Renal benefits of Dapagliflozin. any evidence with DAPA 10mg twice daily dosing for Renal benefits.? | Efficacy | Endocrinology | null |
6,706,377 | 2021-10-15 03:22:00 | HU | Requested article regarding the dapagliflozin improved glycaemic control, stabilized insulin dosing in patients whose T2DM was inadequately controlled on insulin. | Full Article Request | diabetology | null |
5,675,334 | 2021-02-14 11:52:00 | JP | Request: I want to check about FXG Is crushed dosing possible? | Other | 0 | null |
5,340,130 | 2020-10-26 00:00:00 | US | Request: Why is there different renal dosing guidance for glycemic control vs. CV patients when using Farxiga? | DAPA-CKD/Renal Outcomes Related; DAPA-HF; DECLARE Related | 0 | null |
5,159,176 | 2020-08-06 01:00:00 | US | Request: Requesting Copy of Dapa HF trial and interested in non diabetic heart failure pts blood sugar. Also diuretic dosing information when using Farxiga in combination and any untoward events or warnings in the combination population in the study. | DAPA-HF; Drug Interactions/ Combination With; Use in Special Populations | 0 | null |
5,119,082 | 2020-07-22 02:00:00 | US | Request: Send DAPA HF study & is there Data regarding dehydration when Adding Farxiga to a heart failure patient who is already on diuretics. Would there be any change in dosing? | DAPA-HF; Product Related Request | 0 | null |
2,889,705 | 2019-02-13 17:00:00 | US | Request: 2 questions: 1. What data do we have with Farxiga showing risks with causing our seeing increased events of kidney stones while taking Farxiga? (No AE report, but was just questioning). 2. Why does weight loss seen with Farxiga dosing seem to plateau? Is there any other weight loss data seen with Farxiga aside... | Adverse Event | Pharmacist | null |
7,298,319 | 2022-03-30 13:13:00 | CA | Request: Pharmacist called to inquire if we have any data/charts on direct comparisons for SGLT2's for equivalent dosing. For instance, Jardiance vs Forxiga. Kindly call her back, thank you | Dosage; Indications/Uses; Use in Special Populations | 0 | null |
7,020,310 | 2022-01-14 04:00:00 | US | Request: Dr Ogbata has requested visit from nephrology MSL to discuss Farxiga dosing and usage in hospital. He requested to be contacted via email. Siogbata@gmail .com | Dosage | INTERNAL MEDICINE - NEPHROLOGY | null |
6,932,211 | 2021-12-08 08:58:00 | BE | Request received from MSL on 08/12: Hello, I received a question from Dr XXXXXX (Nephrologist in Epicura) a question regarding the action onset and the "peak effect" of dapagliflozin after dosing. Could you please send her the answer ? and eventually send me a copy as well. Here's her email address : XXXXXXX Thanks a l... | Product Basic Information | INME | null |
5,463,543 | 2020-12-30 10:24:00 | US | Request: Is there any dosing data on conversion between other SGLT2 inhibtors to Farxiga if they come into our hospital on another? | Dosage | 0 | null |
6,624,798 | 2021-10-05 00:00:00 | US | Request: Provider requested a summary of the Cardio-Renal Benefits seen across the Declare, Dapa-HF and Dapa-CKD trials. If we have a resource (text or slide) similar to Slide 403 in the Cardio-Renal deck, that is what he is looking for. Also please provide an updated dosing recommendations table for his reference. Tha... | DAPA-CKD/Renal Outcomes Related; DAPA-HF; DECLARE Related | Family Medicine | null |
6,502,257 | 2021-09-14 10:14:00 | CA | Inquiry: Voicemail left by pharmacist dated on September 14th, 2021 at 10:14 am. The pharmacist has a question in regards to FORXIGA and XIGDUO, she has a patient who suffers from dysphagia and she would like to know if it's possible to crush the tablets? The pharmacist/requestor had left a message with a callback numb... | Administration | 0 | null |
6,463,781 | 2021-09-01 07:14:00 | CA | Inquiry: Can you please provide direction for the physician with regards to Forxigas new chronic kidney disease indication? What are EGFR cutoffs on which to initiate and terminate Forxiga, dosing and patient populations. | DAPA-CKD/Renal Outcomes Related; Dosage; Precautions and Contra-Indications; Product Basic Information; Use in Special Populations | GEPR | null |
6,119,912 | 2021-06-01 06:54:00 | GB | One of my Diabetes Consultants has asked me if the dosing thresholds in renal impairment are likely to change for Forxiga. I am, therefore, enquiring if there are any plans for this? | Dosage; Precautions and Contra-Indications; Use in Special Populations | 0 | null |
6,021,887 | 2021-05-12 14:00:00 | US | Request: Are there any changes in dosing for a patient with hepatic issues? | Use in Special Populations | Family Medicine | null |
5,734,299 | 2021-02-23 02:00:00 | AU | Request: Hi the doctor would like to enroll a patient in the forxiga PFP. The patient meets all the eligibility criteria for the program however, they are a type 1 diabetic on insulin. The GP is happy to manage the patients insulin dosing. I am just checking to see for the GP whether or not he can enroll this patient. ... | Compassionate Use | 0 | null |
5,686,180 | 2021-02-16 04:00:00 | US | Request: Dr. Bustos would like some additional information around prescribing Farxiga 10 mg in combination with a more potent diuretic torsemide. Nephrologists prescribe torsemide for their patients and he would like to gain some additional medical information around the proper dosing with Farxiga and Torsemide in comb... | Drug Interactions/ Combination With | 0 | null |
5,510,887 | 2021-01-12 08:49:00 | JP | Request: Do you have any information on suspension dosing of FXG10mg? | Other | 0 | null |
6,464,108 | 2021-09-01 00:00:00 | CA | Request: Please send product monograph for reference and please include a short summary of the new indication including dosing - easier to read and refer to | DAPA-CKD/Renal Outcomes Related; Dosage; Indications/Uses; Product Basic Information | General Practice | null |
6,462,762 | 2021-08-31 01:00:00 | CA | Request: Please send summary of new indication, dosing, egfr threshold - product monograph and study too wordy to have on reference. Summary of trial results and conclusion would be helpful if that could also be sent | DAPA-CKD/Renal Outcomes Related; Dosage; Indications/Uses; Product Basic Information | 0 | null |
3,222,499 | 2019-05-09 03:21:00 | JP | Request: Please tell me the above dosing data and case reports if there are any. | Efficacy | 0 | null |
3,766,153 | 2019-10-16 08:00:00 | CA | Request: Dr. Kwok Ng would like to know if there are any adjustments to dosing that need to be made to elderly patients who are thin and over 65 Also wants summary of Dapa HF (see #03765611) | Use in Special Populations | 0 | null |
5,254,084 | 2020-09-28 09:47:00 | JP | Request: Please tell me the dosing period for the design of the DAPA-HF exam. | DAPA-HF | 0 | null |
5,233,509 | 2020-09-23 08:58:00 | CA | 2020-08-28 04:28:49 Session ID: 5e24a8c0-ebb1-4084-9fb4-56958ef16e9d user input: Dosing/ what are the indications | Dosage; Indications/Uses | 0 | null |
5,166,575 | 2020-08-17 02:00:00 | US | Request: Please provide details on DAPA Hf trial design. Particularly, specifics of indication in Hf in non-diabetics as well as diabetics, is there a need for different dosing? Meaning if they are on current treatment for Hf, including lasix or Entresto, how do we handle the potential for volume depletion with Farxiga... | Adverse Event; DAPA-HF; Dosage | 0 | null |
5,098,621 | 2020-07-15 08:00:00 | US | Request: Please provide me with dosing used among the 11% pts on Entresto on DAPA_HF? Did they titrate up to the Max dose? Also I like to see what dose of all other standard of care drugs were used? | DAPA-HF | 0 | null |
4,634,711 | 2020-02-26 01:43:00 | AU | Dear xx, Thank you for our meeting last week. You shared some really insightful observations that are very helpful for us. I have passed on your suggestions to marketing about the patient materials, and Mara from our commercial team should be in contact with you shortly to pass on the materials you were after. There we... | DAPA-HF; DECLARE Related; Drug Interactions/ Combination With | 0 | null |
4,633,902 | 2020-02-25 09:41:00 | CA | Asking about BID dosing for forxiga related to effects on urinary excretion | Product Related Request | 0 | null |
4,247,517 | 2019-12-09 08:14:00 | AU | Jasper 2019AU02046 AE 4248154 Rep received report from pharmacist of doctor prescribing Xigudo 5/1000mg 2 bd - when pharmacist questioned the dosing prescriber advised he always prescribs xigduo with bd dosing . Patient has received the script before as well - pharmacist advised doctor has gotten special authority from... | Adverse Event | 0 | null |
3,801,264 | 2019-10-22 07:00:00 | ZA | Request: The dr requested page S54 2017 semdsa guidelines treatment algorithm. The Dr also requested info regarding dosing and cost of Forxiga plus package insert. | Efficacy; Indications/Uses | 0 | null |
3,757,546 | 2019-10-15 03:00:00 | CA | Request: Please send me the Dapa HF Trial, also dosing in the Trial | DAPA-HF; Full Article Request; Product Related Request; Therapeutic Area Related Request | 0 | null |
5,320,053 | 2020-10-14 08:22:00 | JP | Request: I want to check about FXG Do you have any data that examined pulverized dosing? | Other | 0 | null |
3,752,275 | 2019-10-14 02:00:00 | US | Request: Is there any data to support using farxiga for patients who can’t afford to lose weight and is there any data to,support using farxiga every other day or alternative dosing regimens? | Adverse Event; Product Basic Information; Use in Special Populations | 0 | null |
3,569,392 | 2019-09-11 10:31:00 | JP | Request: I received instructions for split administration of half tablets of FXG. Is such a dosing method possible? | Other | 0 | null |
3,556,041 | 2019-09-05 00:55:00 | JP | Request: ① I wanted you to provide FXG's patient guidance notes (A4 size, a type that can be removed one by one like a stationery paper), so I contacted you. ② I would like you to provide the following materials this time. * There is no clear date designation. Good at offering when ready. ・ “Materials for Fosiga Patien... | Other | 0 | null |
3,555,377 | 2019-09-04 03:00:00 | US | Request: Please advise on medication use when EGFr goes low? How do you proceed with dosing of Farxiga? | Dosage; Efficacy; Use in Special Populations | 0 | null |
3,419,535 | 2019-07-23 07:29:00 | JP | Request: We were contacted when we had a Fosiga Tablets customer meeting. Section of the DIPECT-2 trial safety (52 weeks). One case of death in the Fosiga 5 mg+INS group was confirmed during the 52-week prolonged dosing period. There is, but I would appreciate it if you could tell me about the detailed information. | Adverse Event | 0 | null |
3,361,342 | 2019-07-05 00:00:00 | NZ | Request: Elaine asked for clarification on dosing for hepatically impaired patients. I have provided information from the NZ datasheet around this and Elaine mentioned that there is a NZ formulary resource which recommends starting at 5mg of Forxiga in hepatically impaired patients. https://nzf.org.nz/nzf_70056. I have... | Use in Special Populations | 0 | null |
3,297,901 | 2019-06-16 08:51:00 | JP | Request: ① Is it possible to administer FXG10twice a day? ② Should I check with the prescribing doctor if I receive instructions for dosing twice a day? ③ Will insurance pass if administered twice a day? | Other | 0 | null |
3,280,414 | 2019-06-05 07:35:00 | JP | Request: I answered a question from Dr. that I wanted to know the onset status of Japanese people with cerebral infarction, but I would like you to tell me about the period of taking medication until each onset, age, and presence or absence of stroke history There was a request. As a test, we can tell you about domesti... | Adverse Event | 0 | null |
5,311,445 | 2020-10-12 04:00:00 | US | Request: Dr. Fish has asked if we have any data on intermittent dosing for dapagliflozin and efficacy or safety effects vs. daily dosing. I.e., taking every other day, or only on weekdays vs. every day. I placed this MIR separately as I assumed this search would take longer and didn't want to delay getting her already ... | Dosage; Off-label | 0 | null |
5,330,907 | 2020-10-18 09:00:00 | AU | JASPER ID: 2020AU02509 Request: Could you please provide information on dosing 5mg of Forxiga - also breaking the 10mg tablets in half to give to patients. AE reported. | Administration; Adverse Event; Off-label | 0 | null |
README.md exists but content is empty.
- Downloads last month
- 6